Network pharmacology analysis uncovers the mechanism of Shudihuang-Shanzhuyu herb pair in prevention and treatment of diabetic osteoporosis via PI3K/AKT pathway
- 5 March 2025
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 345, 119581
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82370498)
This publication has 45 references indexed in Scilit:
- Skeletal Response to Insulin in the Naturally Occurring Type 1 Diabetes Mellitus Mouse ModelJBMR Plus, 2021
- An update on β-sitosterol: A potential herbal nutraceutical for diabetic managementBiomedicine & Pharmacotherapy, 2020
- HSP90 inhibitors strengthen extracellular ATP‐stimulated synthesis of interleukin‐6 in osteoblasts: Amplification of p38 MAP kinaseCell Biochemistry and Function, 2020
- The Interrelationship Between Diabetes, IL-17 and Bone LossCurrent Osteoporosis Reports, 2020
- microRNA-7 inhibition protects human osteoblasts from dexamethasone via activation of epidermal growth factor receptor signalingMolecular and Cellular Biochemistry, 2019
- Role of GAB1/PI3K/AKT signaling high glucose-induced cardiomyocyte apoptosisBiomedicine & Pharmacotherapy, 2017
- Efficacy of Osteoporosis Therapies in Diabetic PatientsCalcified Tissue International, 2016
- Differential effects between the loss of MMP-2 and MMP-9 on structural and tissue-level properties of boneJournal of Bone and Mineral Research, 2010
- The bone marrow microenvironment contributes to type I diabetes induced osteoblast deathJournal of Cellular Physiology, 2010
- Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture riskDiabetologia, 2005